ResearchCA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation
ResearchDIRAS3 Inhibits Ovarian Cancer Cell Growth by Blocking the Fibronectin-Mediated Integrin β1/FAK/AKT Signaling Pathway
ResearchQuantitative proteomics identifies conserved proteins and altered regulation of mucin-16 in low grade serous ovarian cancers
ResearchDIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomas
ResearchAutoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer
ResearchA novel SIK2 inhibitor SIC-19 exhibits synthetic lethality with PARP inhibitors in ovarian cancer
ResearchIL-2-free tumor-infiltrating lymphocyte therapy with PD-1 blockade demonstrates potent efficacy in advanced gynecologic cancer
ResearchCrizotinib Enhances PARP Inhibitor Efficacy in Ovarian Cancer Cells and Xenograft Models by Inducing Autophagy
ResearchAmyloid-like p53 as prognostic biomarker in serous ovarian cancer—a study of the OVCAD consortium
ResearchSIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers